The Red
Flags That
Make Me Walk.

I get asked the same question constantly: what would make you walk away from a DTC brand. People expect a long list. It is not. The genuine deal killers are few and specific, and most of the things buyers panic about are not on it.

The mistake I see again and again is buyers overweighting cosmetic problems while underweighting the structural ones. They walk from a brand because the founder is burned out and the warehouse is a mess, then chase a brand with beautiful operations and a cohort curve that is quietly collapsing. The first is fixable in a quarter. The second is terminal.

So let me separate them. Here is what actually scares me, and here is what does not.

Killers and
fixables are
not the same.

A deal killer is a problem that does not respond to capital or competence. You cannot buy your way out of it, and you cannot operate your way out of it on any reasonable timeline. A fixable problem is the opposite: it looks ugly, it lowers the price, and a capable operator clears it inside a year. The whole game is putting each problem in the right bucket.

Buyers get this backwards because the fixable problems are visible and the killers are buried. Burnout shows up in the first call. A deteriorating cohort curve hides three layers down in the data room. The visible problems get priced in. The invisible ones get you.

Platform
dependence
without a brand.

The first real killer: a business that depends entirely on a platform and has built no brand equity underneath it. A pile of revenue that exists only because of one ad account, one marketplace ranking, or one algorithm's current mood is not a brand. It is a position, and positions get taken.

The tell is the absence of earned demand. No one searches for the brand by name. There is no email base that opens and buys without a discount. There is no organic or direct traffic worth mentioning. If the only reason customers arrive is paid acquisition, then the moment costs rise or the algorithm shifts, the whole thing unwinds, and you cannot fix it by spending more. You inherit the same trap.

Cohort quality
going the
wrong way.

The second killer is the one people miss most: cohort quality that is deteriorating over time. Total revenue can look flat or even up while the underlying customer behavior rots. If the cohorts you acquired this year repeat less, spend less, and churn faster than the cohorts from two years ago, the business is hollowing out from the inside. The fastest way to see it is to run the brand's CAC payback by vertical and its contribution margin by cohort: when both drift the wrong way, the decline is already priced into the future.

This matters because you are buying the future, not the past. A flat top-line built on worsening cohorts is a top-line that falls off a cliff once the acquisition spend can no longer paper over it. I treat this as close to non-negotiable. A brand whose recent cohorts are clearly worse than its older ones is a brand I price for decline or I walk. The connection between this and where a brand sits on its growth curve is the thing most buyers never properly weigh.

The supplier
risk nobody
disclosed.

The third killer is undisclosed single-supplier fragility. A brand that sources its hero product from one factory, with no second source, no formal contract, and a relationship that runs on the founder's personal rapport, is sitting on a fault line. If that factory raises prices, gets bought, has a quality failure, or simply stops returning calls after the founder leaves, the brand's best-selling product can go dark.

What makes this a killer rather than a fixable is the word undisclosed. If a seller is upfront about supplier concentration and there is a credible path to a second source, that is a fixable I can plan around. When I find it buried, after the seller framed supply as a non-issue, it tells me two things: the risk is real, and the seller either did not understand their own business or hoped I would not look.

A business
that needs the
seller to stay.

The fourth killer is a brand that only works if the seller keeps working. If the founder is the brand's voice, the supplier relationship, the ad strategist, and the head of product all at once, you are not buying a transferable business. You are buying a dependency on a person who has already decided to leave. Earnouts and consulting agreements paper over this for a while, but the day they end, the thing you bought walks out the door.

The distinction matters: a founder who is involved but has built a team and documented the playbook is fine. A founder who is the single point of knowledge for everything that makes the brand work is a killer. I dig into this hard in the first 48 hours of any deal, because it is the failure mode that ambushes buyers most often after close.

The problems
that are really
just discounts.

Now the other side. Seller burnout scares a lot of buyers. It does not scare me, it excites me. A burned-out founder who has stopped innovating on a brand with real demand is often the best deal on the table, because the price reflects the fatigue and the upside reflects what fresh energy and capital can do. The brand is fine. The driver is just tired.

Clunky operations are the same story. A messy warehouse, a bloated app stack, a support backlog, a chaotic spreadsheet running the whole business. These look alarming and they are entirely fixable. They are process problems, and process is what a competent operator brings. If anything, operational mess in a brand with good demand is a margin opportunity hiding in plain sight.

A concentrated catalog falls in the same bucket more often than people think. A brand doing most of its revenue from three products is risky in theory, but if those products have real demand and the brand has room to extend the line, that concentration is a starting point, not a death sentence. Compare that to the killers above and the difference is obvious: one is a position you can build from, the others are foundations that are already cracking.

The discipline is simple to say and hard to hold: walk from the killers, negotiate against the fixables, and never confuse the two. If you want the front end of this process, start with the 48-hour screen I run before any deal, then bring me the one that survives it.